Travere Therapeutics, Inc. Profile Avatar - Palmy Investing

Travere Therapeutics, Inc.

Travere Therapeutics, Inc., a biopharmaceutical company, focuses on the identification, development, commercialization, and delivering of therapies for the treatment of rare diseases. Its marketed products include Chenodal, a synthetic oral form of cheno…

Biotechnology
US, San Diego [HQ]
Similar Stocks · Benchmarked Analysis · Peer Group

Peers Performance

A quick analysis that compared Travere Therapeutics, Inc. (TVTX) to it's peer group.

Peer Group
Loading...
End of TVTX's Analysis
CIK: 1438533 CUSIP: 89422G107 ISIN: US89422G1076 LEI: - UEI: -
Secondary Listings
TVTX has no secondary listings inside our databases.